Clarkson, the former co-host of the globally popular and long running BBC show, "Top Gear," told CNN's "Quest Means Business" that the new series is "'Top Gear' in witness protection."
"That's what a friend of mine said the other day, a reviewer. [This show] is different because it moves around the world, that's really it," Clarkson told CNNMoney anchor Maggie Lake. "But it's still James [May], Richard [Hammond], and I. So it's like if you have a glass of champagne and you have it in a bucket or in a glass, it's still champagne, and that's really what it is. It's a different vessel, but the show is, with different elements, basically about the same."
According to Amazon, the premiere episode of "The Grand Tour" was the subscription service's most-watched premiere since "The Man in The High Castle."
Clarkson and his co-hosts are on Amazon instead of the BBC because Clarkson was fired by the BBC for punching a producer, Oisin Tymon. It was the last straw for the BBC, which had weathered a number of controversies involving Clarkson, including racist and homophobic comments he made over the years. But it doesn't sound like Clarkson is planning on reining himself in.
great stocks to own: Progenics Pharmaceuticals Inc.(PGNX)
Advisors' Opinion:- [By Lisa Levin]
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) shares shot up 29 percent to $6.37 after announcing the FDA approval of RELISTOR tablets for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.
- [By Ben Levisohn]
After meeting with the senior management team of Progenics (PGNX) , Valeant’s partner for oral Relistor, we continue to think that this drug would be a good addition to Valeant’s GI (gastrointestinal) franchise. The PDUFA date for oral Relistor is 7/19/16. Although�Valeant is leading interactions with the FDA, Progenics is highly confident regarding an approval in July based on its discussions with Valeant. Progenics believes that oral Relistor could be a $1B+ opportunity for Valeant, even with the recent decrease in opioid usage. For context, we estimate ’16 sales of $9.9B for Valeant. An approval for oral Relistor would also help remind the Street that Valeant’s brand drug pipeline is underappreciated, in our view. We think pipeline advancements for brand drugs could drive multiple expansion for�Valeant shares (on P/E).
great stocks to own: First Commonwealth Financial Corporation(FCF)
Advisors' Opinion:- [By SEEKINGALPHA.COM]
The last year Netflix generated positive free cash flow (FCF), was 2010, which happens to coincide with the year it began significantly increasing its content library, per Figure 2 above. Since then, Netflix has burned through cumulative $3.6 billion in cash, per Figure 3, and the cash burn is only accelerating. In 2015, NFLX's FCF sat at -$1.6 billion, and over the last twelve months, FCF has worsened to -$1.9 billion.
great stocks to own: Dean Foods Company(DF)
Advisors' Opinion:- [By Monica Gerson]
Dean Foods Co (NYSE: DF) is expected to report its quarterly earnings at $0.38 per share on revenue of $1.89 billion.
Electronic Arts Inc. (NASDAQ: EA) is estimated to post its quarterly earnings at $0.42 per share on revenue of $888.78 million.
- [By Monica Gerson]
Analysts are expecting Dean Foods Co (NYSE: DF) to have earned $0.38 per share on revenue of $1.89 billion in the latest quarter. Dean Foods shares slipped 0.30 percent to $18.15 in after-hours trading.
great stocks to own: Coach, Inc.(COH)
Advisors' Opinion:- [By Teresa Rivas]
Coach (COH) is climbing Tuesday, following its upbeat third-quarter report.
Bloomberg NewsThe handbag maker said it earned 44 cents a share on revenue of $1.03 billion. Analysts were looking for earnings of 41 cents on revenue of $1.02 billion.
The company also reiterated its full-year guidance, as it expects low-single-digit revenue growth.
Bulls include Cowen & Co.��s Oliver Chen, who reiterated an Outperform rating and $46 price target on the stock:
For Coach brand, N. America sales were $499mm vs. Cowen’s $484mm & Street’s $481mm. Total Coach brand N. America comps were flat y/y vs. Cowen’s -1% in-line with Street. As expected , at POS, sales in N. America department stores declined at a -MSD rate vs. LY given the lack of clearance inventory, while net sales into department stores rose slightly. International sales were $448mm (+7% C/C) vs. Cowen’s $456mm & Street’s $452mm. China sales were -2% (+2% C/C) with +DD growth and positive comp store sales on the Mainland offset in part by continued weakness in Hong Kong & Macau. In Japan, sales rose +7% C/C, despite a decrease in square footage, while dollar sales rose +8%, reflecting the stronger yen. Sales for the remaining directly operated businesses in Asia posted solid growth in C/C but rose slightly in dollars, while Europe remained very strong, growing at a +DD pace driven by both comp store sales and distribution increases.
Wells Fargo��s Ike Boruchow reiterated an Outperform rating and raised his valuation range from $45 to $47, from $43 to $45:
With expectations creeping up into its Q3 print, COH delivered better North American (NA) comps (0% vs. Street��s -1.5%) and EPS ($0.44 vs. Street��s �$0.41) �� which keeps the bull case firmly on the table as management continues �to gain traction on its turnaround efforts. Digging deeper into the improving �domestic performance, some key details coming out of th
- [By Ben Levisohn]
Shares of Michael Kors Holdings have soared 24% to $49.99 at 3:23 p.m. today, while Kate Spade (KATE) has risen 1.9% to $18.19, and Coach (COH) has dropped 0.5% to $37.02.
- [By Chris Lange]
When Coach Inc. (NYSE: COH) released its fiscal first-quarter earnings report before the markets opened on Tuesday, it posted $0.45 in earnings per share (EPS) and $1.04 billion in revenue. Thomson Reuters consensus estimates had called for $0.45 in EPS and revenue of $1.07 billion. The same period of last year reportedly had EPS of $0.41 and $1.03 billion in revenue.
- [By Trey Thoelcke]
In its 75th anniversary year, Coach Inc. (NYSE: COH) has just announced the opening of its newest flagship store, Coach House, on Fifth Avenue in New York City, one of the world��s most prestigious shopping districts.
- [By Ben Levisohn]
Now that the Olympics are underway, we’ll have a chance to see athletes try to leap ever higher bars. Today, we got to watch Coach (COH), which reported better than forecast earnings, fail to make the jump. RBC’s�Brian Tunick and Bilun Boyner explain:
- [By Ben Levisohn]
But in the what-have-you-done-for-me-lately world of the stock market, that was the past, and the present and future, well they don’t look so hot. For the third quarter, the Vera Bradley, which competes against Coach (COH) and Michael Kors (KORS), among others, now expects sales between�$128 million to $130 million, below forecasts for about $147 million, and a profit of 30 cents to 35 cents, below forecasts for a 48-cent profit. In 2014, Vera Bradley expects sales of�$535 million to $540 million, below forecasts for $575, while its earnings should come in between�$1.47 and $1.52, below expectations of $1.72.�And did I mention that its margins are expected to decline too?�
great stocks to own: Thor Industries Inc.(THO)
Advisors' Opinion:- [By Lisa Levin]
Shares of Thor Industries, Inc. (NYSE: THO) got a boost, shooting up 14 percent to $102.70 as the company reported stronger-than-expected results for its first quarter on Monday.
